tocilizumab (06-9-2017)

Class: Biologic Therapy Generic Name: tocilizumab Trade Name: Actemra® How is this drug used? Actemra is approved for adults with moderate to severe rheumatoid arthritis (RA) when one or more other Disease Modifying Anti-Rheumatic Drugs (DMARDs) have... Continue Reading

telotristat ethyl (03-15-2017)

Class: Supportive Care Generic Name: telotristat ethyl Trade Name: Xermelo For which conditions is this drug approved? Telotristat ethyl is approved to be used in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid... Continue Reading

Tecentriq® (06-8-2016)

Class: Biological Therapy Generic Name: atezolizumab Trade Name: Tecentriq® How is this drug used? Tecentriq is approved for patients with metastatic non-small cell lung cancer (NSCLC) whose disease progressed during or following therapy with a platinum... Continue Reading

talimogene laherparepvec (04-6-2016)

Class: Viral Therapy Generic Name: talimogene laherparepvec Trade Name: Imlygic For which conditions is this drug approved? Imlygic can be used to treat melanomas in the skin or lymph nodes that can’t be removed with surgery. What is the mechanism... Continue Reading

Tagrisso (03-28-2016)

Class: Biological Therapy Generic Name: osimertinib Trade Name: Tagrisso® For which conditions is this drug approved? Tagrisso is a kinase inhibitor used to treat patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive... Continue Reading

Talimogene Laherparepvec (01-19-2016)

Class: Biological Therapy Generic Name: Talimogene Laherparepvec Trade Name: Imlygic® For which conditions is this drug approved? Imlygic is approved to treat patients with advanced melanoma that has come back after initial surgery. What is the mechanism... Continue Reading

Total body irradiation (TBI) (12-22-2015)

TBI is a radiation treatment to the entire body. It is used to destroy cancer cells and bone marrow cells in preparation for a bone marrow or peripheral stem cell transplantation.  Read More →

Treat to Target (11-16-2015)

a common management strategy for rheumatoid arthritis that sets a goal of significant improvement from treatment at 3 months and attainment of the treatment target at 6 months. This strategy is influenced by the choice of treatment, disease activity assessment... Continue Reading

Trabectedin (11-5-2015)

Class: Chemotherapy Generic Name: Trabectedin Trade Name: Yondelis® For which conditions is this drug approved? Yondelis is approved for the treatment of adults with liposarcoma or leiomyosarcoma that cannot be treated with surgery or has spread to other... Continue Reading

Trigger point (10-6-2015)

A focal area of accentuated muscle tenderness  Read More →

Next Page »